Netflix’s Earnings Rebound, Surveying the Airline Stocks, and BioMarin CEO 10/19/22
Netflix soared today after earnings, and Jim Cramer’s walking you through how the streaming company pulled it off this quarter. Then, are Delta and United worth buying after rebounding from their lows? Cramer’s giving you his take on owning the airlines. And, Cramer’s sitting down with the Chairman and CEO of BioMarin Pharmaceutical, to get a closer look at the company’s pipeline and where the stock could be headed.
October 19, 202244m 30s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Netflix soared today after earnings, and Jim Cramer’s walking you through how the streaming company pulled it off this quarter. Then, are Delta and United worth buying after rebounding from their lows? Cramer’s giving you his take on owning the airlines. And, Cramer’s sitting down with the Chairman and CEO of BioMarin Pharmaceutical, to get a closer look at the company’s pipeline and where the stock could be headed. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.